Clinical trial

Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients

NCT00420771 · New York State Psychiatric Institute, Other · Completed

Key facts

NCT number NCT00420771
Title Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients
Official title A Randomized Controlled Pilot Trial of Gabapentin for the Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients
Lead sponsor New York State Psychiatric Institute, Other
Collaborators National Institute on Drug Abuse (NIDA) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Benzodiazepine Dependence, Opioid Dependence
Intervention type Drug
Interventions Gabapentin, Placebo
Enrollment 19
Start date Jan 1, 2007
Primary completion Jan 1, 2011
Completion Jan 1, 2011
First posted Jan 11, 2007
Last update posted Apr 24, 2019
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies